The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population
1 other identifier
interventional
149
1 country
1
Brief Summary
The purpose of the study is to examine the safety and effectiveness of the use of coconut oil for the prevention and treatment of diaper dermatitis among NICU babies at Genesis Medical Center, Davenport.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2015
CompletedFirst Posted
Study publicly available on registry
November 25, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedResults Posted
Study results publicly available
October 15, 2024
CompletedOctober 15, 2024
September 1, 2024
3.5 years
November 16, 2015
December 9, 2021
September 23, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
The Number of Days Free From Diaper Dermatitis
The number of days free from diaper dermatitis.
Once, at hospital discharge, an average of 2 weeks
The Number of Patients Experiencing Adverse Events
The number of patients experiencing adverse events.
Once, at hospital discharge, an average of 2 weeks
Secondary Outcomes (1)
The Percent of Parents Stating Satisfaction With the Diaper Dermatitis Treatment Used
Once, at study completion for hospital discharge, an average of 2 weeks
Study Arms (2)
Coconut Oil
EXPERIMENTALParticipants in this group will receive a generous layer of organic, unrefined coconut oil applied to the diaper area (buttocks and creases between thighs and hips) at each diaper change. This will continue until the patient is discharged or reaches the primary safety endpoint (skin that is eroded and/or blistered in the diaper area with bleeding).
Standard of Care
ACTIVE COMPARATORParticipants in this group will receive the standard of care for preventing and treating diaper dermatitis at Genesis. This includes no treatment until a diaper dermatitis appears. If diaper dermatitis appears, participants will receive a generous layer of Medline Remedy Phytoplex Z-Guard Skin Protectant applied to the diaper area (buttocks and creases between thighs and hips) at each diaper change. This will continue until the patient is discharged or reaches the primary safety endpoint (skin that is eroded and/or blistered in the diaper area with bleeding).
Interventions
Eligibility Criteria
You may qualify if:
- Babies admitted to the Genesis NICU
- Anticipated stay in the NICU is ≥ 48 hours
- Babies wearing diapers 24 hours a day
- Parent willing to sign informed consent for the study
- Parent willing to use the test products in the diaper area during the trial
- Parent willing to not change the type or brand of diaper and wipes during the study
- Parent willing to refrain from changing any other products whose use may have an effect of their baby's skin condition during the trial
You may not qualify if:
- Babies with a gestational age \<30 weeks
- Babies with major congenital malformations
- Active dermatological conditions other than diaper dermatitis that may affect trial results
- Known sensitivity to ingredients in trial products
- Babies whose parents have a hazelnut or coconut allergy
- Other severe acute medical conditions that may increase the risk associated with trial participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Genesis Medical Center, East Campus
Davenport, Iowa, 52803, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michelle Martin, RN
- Organization
- Genesis Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2015
First Posted
November 25, 2015
Study Start
January 1, 2016
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
October 15, 2024
Results First Posted
October 15, 2024
Record last verified: 2024-09